Search details
1.
Silent mutations reveal therapeutic vulnerability in RAS Q61 cancers.
Nature
; 603(7900): 335-342, 2022 03.
Article
in English
| MEDLINE | ID: mdl-35236983
2.
Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinoma.
Br J Cancer
; 126(3): 430-439, 2022 02.
Article
in English
| MEDLINE | ID: mdl-35046520
3.
Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment.
Clin Cancer Res
; 2024 May 02.
Article
in English
| MEDLINE | ID: mdl-38695832
4.
Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14-Mutant NSCLC.
Clin Cancer Res
; 26(11): 2615-2625, 2020 06 01.
Article
in English
| MEDLINE | ID: mdl-32034073
5.
Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations.
Cancer Res
; 80(10): 2017-2030, 2020 05 15.
Article
in English
| MEDLINE | ID: mdl-32193290
6.
Genomic Profiling for KRAS, NRAS, BRAF, Microsatellite Instability, and Mismatch Repair Deficiency Among Patients With Metastatic Colon Cancer.
JCO Precis Oncol
; 32019.
Article
in English
| MEDLINE | ID: mdl-32923867
7.
Inherited Cancer in the Age of Next-Generation Sequencing.
Biol Res Nurs
; 20(2): 192-204, 2018 03.
Article
in English
| MEDLINE | ID: mdl-29325452
Results
1 -
7
de 7
1
Next >
>>